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eart Rate Response During Exercise Predicts
urvival in Adults With Congenital Heart Disease
erhard-Paul Diller, MD,*† Konstantinos Dimopoulos, MD,* Darlington Okonko, BSC, MRCP,†
nselm Uebing, MD,* Craig S. Broberg, MD,* Sonya Babu-Narayan, MRCP,* Stephanie Bayne, BSC,*
hilip A. Poole-Wilson, MD, FRCP,† Richard Sutton, DSCMED,‡ Darrel P. Francis, MA, MRCP,§
ichael A. Gatzoulis, MD, PHD*
ondon, United Kingdom
OBJECTIVES To assess the prognostic value of heart rate response to exercise in adult congenital heart
disease (ACHD) patients.
BACKGROUND An abnormal heart rate response to exercise is related to autonomic dysfunction and may have
prognostic implications in ACHD.
METHODS We identified 727 consecutive ACHD patients (mean age [ SD] 33  13 years) with
varying diagnoses and without pacemakers. Peak oxygen consumption (peak VO2), resting
heart rate, and the increase in heart rate from resting level to peak exercise (“heart rate
reserve”) were measured. We also quantified the decrease in heart rate (“heart rate recovery”)
after cessation of exercise.
RESULTS During a median follow-up of 28 months, 38 patients died. Lower values of heart rate reserve,
peak heart rate, heart rate recovery, and peak VO2 (p  0.01 for each) were associated with
increased mortality in univariate analysis. Furthermore, heart rate reserve predicted mortality
independently of antiarrhythmic therapy, functional class, and peak VO2. Stratifying patients
by diagnostic groups revealed that a lower heart rate reserve was also associated with a greater
risk of death in patients with complex anatomy, Fontan circulation, and tetralogy of Fallot
(p  0.05 for each).
CONCLUSIONS An abnormal heart rate response to exercise identifies ACHD patients with a higher risk of
mortality in the midterm, even after accounting for antiarrhythmic medication and exercise
capacity. Heart rate reserve is a simple and inexpensive way to identify ACHD patients at
higher mortality risk. (J Am Coll Cardiol 2006;48:1250–6) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.05.051College of Cardiology Foundation
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pith advances in surgical management, an increasing num-
er of patients with congenital heart disease reach adult-
ood (1,2). Such patients have a higher mortality over the
edium and long term compared with healthy individuals
ith similar demographic characteristics (3–7). Develop-
ent of simple risk stratification methods would permit
esources to be directed to patients with adult congenital
eart disease (ACHD) at greatest risk. Cardiopulmonary
xercise testing with measurement of peak oxygen con-
umption is increasingly used in ACHD patients because it
ay provide similar prognostic information in ACHD as it
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merican Heart Association Scientific Sessions, Dallas, Texas, November 13, 2005.e
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ccepted May 22, 2006.oes in patients with acquired heart disease. Measuring peak
xygen consumption, however, requires expensive equip-
ent and specific expertise and is therefore not widely
vailable.
Chronotropic incompetence—a blunted increase in heart
ate during exercise—is an established predictor of mortality
n patients with coronary artery disease and in healthy
opulations (8–10). Little is known about its prevalence and
rognostic implications across the spectrum of ACHD.
ttenuation of heart rate recovery—the rate of decrease in
eart rate after cessation of exercise—also is associated with
ncreased mortality in patients being assessed for coronary
rtery disease (11). Because cardiac autonomic dysfunction
s common in ACHD patients (12,13), we hypothesized
hat abnormal heart rate response to exercise may also be
ommon in ACHD and could be a simple means of risk
tratification.
The aims of this study were: 1) to evaluate the prevalence
f an abnormal heart rate response to exercise (chronotropic
ncompetence) in ACHD patients; 2) to assess the relation-
hip between heart rate response and exercise capacity; and
) to evaluate whether chronotropic incompetence is a
rognostic marker in ACHD patients after accounting for
xercise capacity and use of antiarrhythmic medication.
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tudy population. This was a retrospective study. We
nalyzed data from all cardiopulmonary exercise tests per-
ormed in ACHD patients at our institution between
ebruary 1999 and April 2005. Patients were referred for
xercise testing as part of a protocolized clinical follow-up
or ACHD patients. This study was approved by the local
thics committee. Almost all patients underwent only 1 test
uring the study period. Any repeat test was not included in
he analysis. A main diagnosis was determined for every
atient from the hospital records. If more than 1 cardiac
esion was present, the lesion considered hemodynamically
ost important was recorded as the main diagnosis. Pa-
ients with multiple complex cardiac lesions substantially
ffecting hemodynamics were classified as complex anat-
my. The New York Heart Association (NYHA) functional
lass was determined by physician assessment of patients’
elf-reported symptoms before the date of the exercise test.
ntiarrhythmic drug use was recorded at the time of
xercise testing.
ardiopulmonary exercise testing. Cardiopulmonary ex-
rcise testing was performed on a treadmill according to a
odified Bruce protocol (14,15) with the addition of a
stage 0” in which the patient walks at a velocity of 1 mile/h
nd a gradient of 5% for 3 min. All subjects were encour-
ged to exercise to exhaustion regardless of the maximal
eart rate achieved. Ventilation, oxygen uptake, and carbon
ioxide production were measured continuously using a respi-
atory mass spectrometer (Amis 2000; Innovision, Odense,
enmark) as described previously (16). Heart rate was
ssessed by continuous electrocardiography, and arterial
lood pressure was recorded manually by sphygmomanom-
try. Resting heart rate was measured after at least 30 s in a
eated position, and peak heart rate was defined as the
aximal heart rate achieved during exercise. Predicted
aximum heart rate was estimated according to the Astrand
ormula (220-age) (17), and percentage of maximum age-
redicted heart rate was calculated as the ratio between peak
eart rate and age-predicted maximum heart rate (220-age).
alculation of heart rate reserve. Heart rate reserve was
alculated as the difference between peak and resting heart
ates. The chronotropic index, (peak heart rate  resting
eart rate)/(220-age  resting heart rate) (9), is derived by
pplying the chronotropic metabolic relationship concept
ntroduced by Wilkoff et al. (18) to a symptom-limited
xercise test as described previously (10). This allows defi-
ition of the normal chronotropic response independently
Abbreviations and Acronyms
ACHD  adult congenital heart disease
AUC  area under curve
NYHA  New York Heart Association
ROC  receiver-operating characteristicf age, resting heart rate, and functional state (18). In a oroup of 410 healthy adults,Wilkoff et al. (18) reported 95%
imits of normality of chronotropic index to be 0.8 to 1.3.
ased on this finding, we defined chronotropic incompe-
ence as failure to achieve a chronotropic index of 0.8 (i.e.,
alling below 97.5% of healthy adults).
alculation of heart rate recovery. Heart rate was also
ecorded 1, 2, 3, and 5 min after the cessation of exercise,
nd heart rate recovery was calculated as the difference
etween peak heart rate and the heart rate at these recovery
ime points. In addition, the relative decrement in heart rate
as calculated as heart rate recovery divided by the heart
ate at peak exercise.
ollow-up. Follow-up was complete for all patients. Sur-
ival status and time to death was assessed through the
ealth service computer system, which is linked to a national
atabase held by the Office of National Statistics. We
lanned the study to use all-cause mortality as the end point
o eliminate any possibility of bias arising from incorrect
lassification of cause of death.
tatistical analysis. All values are presented as mean 
tandard deviation. Comparisons between groups were
ade using the Student t test, Mann-Whitney U test, or
hi-square test as appropriate. Variables were assessed
n univariate analysis. Significant parameters were subse-
uently included into a multivariate regression model in a
tepwise forward procedure. Univariate Cox proportional
azards analysis was used to assess the association between
ariables and the end point of all-cause mortality. Parame-
ers significantly predicting prognosis in univariate analysis
ere subsequently tested in a multivariate Cox proportional
azards analysis by the stepwise forward method to assess
he independent effect of these variables. Areas under curve
AUC) for sensitivity and specificity were calculated using
eceiver-operating characteristic (ROC) analysis to compare
rognostic accuracy of different parameters. Statistical anal-
ses were performed using the StatView 5.0 (Abacus Con-
epts, Berkeley, California) and MedCalc 8.2.1 (MedCalc
oftware, Mariakerke, Belgium) software packages.
ESULTS
atient characteristics. Characteristics of the 727 consec-
tive ACHD patients (mean age 33  13 years, 52% male)
ncluded in this analysis are presented in Tables 1 and 2.
atients with chronotropic incompetence were more likely
o be cyanotic, female, or treated with antiarrhythmic drugs.
n addition, by definition, such patients had lower values of
eak heart rate and heart rate reserve, as shown in Table 1.
revalence of chronotropic incompetence. Chronotropic
ncompetence was present in 62% of the patients. The
revalence was highest in patients after Fontan palliation
84%) and in patients with Eisenmenger physiology (90%),
nd it was lowest in patients with repaired tetralogy of Fallot
52%), repaired ventricular septal defect (52%), and isolated
alvar disease (47%), as shown in Table 2. On considering
nly those patients who reached anaerobic threshold (i.e.,
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Heart Rate Response and Survival in ACHD September 19, 2006:1250–6hose with a respiratory quotient below 1.0), the frequency
f chronotropic incompetence was found to be 54% overall.
nce again it was most frequent in the Eisenmenger
atients (96%) and least frequent in patients with repaired
entricular septal defects (35%).
elationship to symptoms and exercise capacity. Patients
ith chronotropic incompetence were more likely to be in
higher NYHA class (34% NYHA class I, 47% NYHA
lass II, 19% NYHA class III) than the remaining patients
64% NYHA class I, 30% NYHA class II, 6% NYHA class
II) (p 0.0001). Patients with chronotropic incompetence
lso had lower peak oxygen consumption (20.4  8.2 ml/kg/
in vs. 28.0  9.9 ml/kg/min; p  0.0001) and shorter
Table 1. Selected Baseline Characteristics Acco
Index of at Least 80%
Characteristic
All Pat
(n  7
Age (yrs) 33 
Gender (% male) 52
Deaths 38
NYHA functional class I/II/III (%) 45/40
Cyanosis (%) 17
Sinus rhythm (%) 96
Class I–IV† anti-arrhythmic drugs (%) 28
Antiarrhythmic drugs incl. digoxin (%) 26
Digoxin (%) 5
Amiodarone (%) 13
Sotalol (%) 4
ACE inhibitors (%) 19
Heart rate reserve (beats/min) 71 
Chronotropic index 0.70 
Peak VO2 (ml/kg/min) 23.3 
Percentage age-predicted heart rate 83 
Peak pulse (beats/min) 154 
Resting pulse (beats/min) 83 
Plus-minus values are mean  standard deviation. *p values
achieving and patients failing to reach a chronotropic index
to Vaughan Williams.
ACE  angiotensin-converting enzyme; NYHA  N
consumption.
able 2. Distribution of Parameters of Chronotropic Incompeten
f Antiarrhythmic Medication by Underlying Anatomy
Low CI
HRR
(beats/min)
Peak Pu
(beats/m
SD (n  42) 60% 69  30 154 
cTGA (n  25) 68% 70  33 151 
oA (n  23) 59% 73  24 156 
omplex (n  75) 81% 56  28 138 
bstein (n  32) 53% 77  28 158 
isenmenger (n  53) 90% 51  23 136 
ontan (n  58) 84% 59  27 140 
ustard (n  56) 58% 77  26 160 
OF (n  228) 52% 80  26 162 
alvar (n  78) 47% 76  31 159 
SD (n  25) 52% 70  27 157 
lus-minus values are mean  standard deviation.
AAD treatment  percentage of patients treated with at least one antiarrhythmic
orrected transposition of the great arteries; CoA aortic coarctation; complex com
U  follow-up period; HRR  heart rate reserve; low CI  percentage of patients
peration for TGA; peak VO2  peak oxygen consumption; sinus rhythm  percentage of p
SD  ventricular septal defect.xercise duration (541  196 s vs. 732  196 s; p 
.0001). In addition, heart rate reserve (r  0.53; p 
.0001) and peak heart rate (r  0.49; p  0.0001)
orrelated with peak oxygen consumption.
rognostic value of parameters of chronotropic incom-
etence. During a median follow-up of 851 days after
ardiopulmonary exercise testing (range 60 to 2,254 days),
8 patients died. The patients who died had the following
iagnoses: Fontan physiology (n  7), complex anatomy
n  10), congenitally corrected transposition of the great
rteries (n  2), atrial switch procedure for transposition of
he great arteries (n  1), tetralogy of Fallot (n  5),
solated valvar disease (n  2), single ventricle physiology
g to the Ability to Reach a Chronotropic
Failed
(n  453)
Reached
(n  274) p Value*
33  13 33  13 0.87
47 61 0.001
34 4 0.0004
34/47/19 64/30/6 0.0001
24 5 0.0001
96 97 0.34
39 10 0.0001
37 7 0.0001
6 4 0.18
19 3 0.0001
5 2 0.02
21 16 0.14
57  24 95  18 0.0001
0.54  0.20 0.96  0.20 0.0001
20.4  8.2 28.0  9.9 0.0001
74  13 97  8 0.0001
138  26 181  14 0.0001
82  16 85  15 0.004
or Mann-Whitney U test) for comparison between patients
east 80%. †Classification of antiarrhythmic drugs according
ork Heart Association class; peak VO2  peak oxygen
eak Oxygen Consumption, Presence of Sinus Rhythm, and Use
Peak VO2
(ml/kg/min)
Sinus
Rhythm
AAD
Treatment
Deceased
During FU
21.6  7.9 89% 32% 1
21.8  9.6 95% 43% 2
28.9  7.9 95% 30% 1
20.2  7.7 88% 35% 10
21.5  5.2 90% 35% 3
12.8  5.7 100% 40% 1
20.9  6.1 96% 53% 7
25.8  6.9 94% 29% 1
25.7  8.4 98% 19% 5
26.9  12.8 97% 17% 2
22.2  7.1 100% 13% 0
including type I–IV or digoxin); ASD  atrial septal defect; ccTGA  congenitally
natomy including mostly single ventricle physiology (excluding Fontan type patients);
low chronotropic index (0.8); Mustard  patients after mustard-type atrial switchrdin
ients
27)
13
/15
29
0.28
9.6
16
30
14
(t test
of at lce, P
lse
in)
34
38
27
32
31
24
33
28
26
29
26
drug (
plex a
with aatients in sinus rhythm at the time of the exercise testing; TOF  tetralogy of Fallot;
(
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n  1), Ebstein anomaly (n 3), repaired atrial (n 1) and
trioventricular (n  2) septal defects, and others (n  2).
On univariate analysis, heart rate reserve, chronotropic
ndex, peak heart rate, and percentage predicted heart rate
redicted survival (Table 3). The other univariate predictors
f survival were use of antiarrhythmic drug therapy, peak
xygen consumption, and NYHA functional class. In addi-
ion, amiodarone or digoxin use was related to survival, as
hown in Table 3. Age, gender, cyanosis, and treatment
ith sotalol, beta-blocker, calcium antagonist, class I anti-
rrhythmic drugs, or angiotensin-converting enzyme inhib-
tors were not related to survival.
Measures of chronotropic response correlated strongly
ith each other (r value between 0.81 and 0.96; p  0.001
or each). Therefore, for multivariate analysis we chose the
arameter with the highest predictive value on univariate
ox proportional hazard analysis and the greatest AUC on
OC analysis. In both analyses, heart rate reserve (chi-
quare  26.1; AUC  0.74) and chronotropic index
chi-square  26.9; AUC  0.74) were superior to peak
eart rate (chi-square 20.9; AUC 0.72) and percentage
ge-predicted peak heart rate (chi-square  21.0; AUC 
.72) in predicting prognosis. As a consequence heart rate
eserve, representing a much simpler parameter than chro-
otropic index, was used in subsequent analyses.
On multivariate analysis, heart rate reserve, NYHA
unctional class, and therapy with antiarrhythmic drugs
ointly predicted mortality, independently of peak oxygen
onsumption, as shown in Table 4. These results remained
nchanged when patients who did not reach the anaerobic
hreshold during exercise (i.e., those with a respiratory
uotient below 1.0) were excluded from the analyses. Figure
illustrates the relationship between heart rate reserve and
eath from any cause among adult congenital heart disease
Table 3. Univariate Predictors of Mortality
Variable
Parameters of chronotropic incompetence
Heart rate reserve (10 beats/min)
Chronotropic index
Peak heart rate (10 beats/min)
Percentage predicted peak heart rate
Heart rate recovery 1 minute (beats/min)
Heart rate recovery 2 minutes (beats/min)
Heart rate recovery 3 minutes (beats/min)
Heart rate recovery 5 minutes (beats/min)
Other univariate predictors
Peak VO2 (ml/kg/min)
NYHA functional class
Antiarrhythmic therapy (excl. digoxin)
Antiarrhythmic therapy (incl. digoxin)
Amiodarone therapy
Digoxin therapy
NYHA class  New York Heart Association functional clasatients stratified by quartiles of heart rate reserve.
brognostic value of heart rate reserve in individual
iagnostic groups. Heart rate reserve predicted mortality
n patients after Fontan palliation (hazard ratio [HR] 
.65 per 10 beats/min; 95% confidence interval [CI] 0.48 to
.88; p  0.05), complex anatomy (HR  0.81 per 10
eats/min; 95% CI 0.65 to 0.998; p  0.05), and repaired
etralogy of Fallot (HR  0.66 per 10 beats/min; 95% CI
.48 to 0.91; p 0.05) on univariate analysis. No significant
ssociation between low heart rate reserve and mortality was
ound in patients with simple lesions, systemic right ventri-
les, or Ebstein anomaly of the tricuspid valve.
omparative prognostic value of heart rate reserve and
eak oxygen consumption. Heart rate reserve was at least
s good as peak oxygen consumption in predicting mortal-
ty, both on univariate Cox analysis (chi-square  26.1 vs.
9.3) and on ROC analysis (AUC  0.74 vs. 0.68) (Fig.
A). Combining these 2 variables was also helpful: Patients
ith both heart rate reserve and peak oxygen consumption
ithin the lowest quartile (51 beats/min and 16.7
l/kg/min, respectively) had the worst prognosis, patients
ith only one in the lowest quartile had an intermediate
Hazard Ratio
(95% Confidence Interval) p Value
0.75 (0.67–0.84) 0.0001
0.97 (0.96–0.98) 0.0001
0.81 (0.74–0.88) 0.0001
0.96 (0.95–0.98) 0.0001
0.96 (0.94–0.98) 0.002
0.96 (0.94–0.98) 0.0002
0.97 (0.95–0.99) 0.001
0.97 (0.96–0.99) 0.0002
0.90 (0.86–0.94) 0.0001
2.8 (1.7–4.5) 0.0001
5.6 (2.8–11.3) 0.0001
6.5 (3.1–13.6) 0.0001
6.9 (3.5–13.5) 0.0001
3.2 (1.2–8.3) 0.016
k VO2  peak oxygen consumption.
able 4. Multivariate Predictors of Mortality
Variable
Hazard Ratio*
(95% Confidence Interval) p Value
eart rate reserve (10 beats/min) 0.86 (0.74–0.99) 0.04
ntiarrhythmic therapy
(incl. digoxin)
3.7 (1.7–8.1) 0.0008
YHA functional class 2.0 (1.2–3.4) 0.007
eak VO2 (ml/kg/min) — NS
eart rate reserve (10 beats/min) 0.83 (0.72–0.96) 0.01
miodarone therapy 4.7 (2.4–9.5) 0.0001
YHA functional class 2.1 (1.3–3.5) 0.002
eak VO2 (ml/kg/min) — NS
Hazard ratios for heart rate reserve and peak oxygen consumption are per 10
eats/min and 1 ml/kg/min, respectively.
Abbreviations as in Table 3.
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Heart Rate Response and Survival in ACHD September 19, 2006:1250–6rognosis, and those with neither in the lowest quartile had
he best prognosis (p  0.0001) (Fig. 1).
rognostic value of heart rate recovery. Data on heart
ate recovery was available in 505 patients (those patients
ho underwent exercise testing after March 2001). Of
hese, 16 patients died during follow-up. Heart rate recovery
t 1, 2, 3, and 5 min was significantly lower in patients who
ied than in surviving patients (p  0.05 for each), as was
eart rate recovery expressed as percentage of peak heart rate
Fig. 2B). Heart rate recovery at 1, 2, 3, and 5 min after
xercise was significantly related to mortality on univariate
ox proportional hazards analysis (p 0.05 for each). After
djustment for antiarrhythmic drug therapy heart rate re-
overy at 1, 2, 3, and 5 min after exercise remained
ndependently predictive of survival in bivariate Cox analysis
p  0.05 for each).
ISCUSSION
his study demonstrates that a blunted heart rate response
o exercise (chronotropic incompetence) is prevalent across
he spectrum of ACHD and predicts an enhanced mortality
isk independently of antiarrhythmic medication. Even an
ttenuated rate of recovery of heart rate after exercise testing
arries important prognostic information. Moreover, a sim-
le combination of heart rate reserve and peak oxygen
onsumption identifies a subpopulation of ACHD patients
ith a 3.8-fold increase in mortality.
Chronotropic incompetence was found to be prevalent
Figure 1. Kaplan-Meier estimates of death from any cause among adult con ACHD, affecting 62% of patients. In other cohorts, the prevalence of chronotropic incompetence ranges be-
ween 30% in patients with chronic heart failure (19) to
0% in patients with chronic atrial fibrillation (20). In the
resent study, the prevalence of chronotropic incompe-
ence was lowest in patients with simple lesions, such as
epaired ventricular septal defect, Ebstein anomaly, or
alliated transposition of the great arteries, and was
ighest in patients with complex, uncorrected, and cya-
otic lesions. This increase in prevalence of chronotropic
ncompetence parallels the decline in peak oxygen con-
umption across the spectrum of ACHD. It has been
uggested that a blunted heart rate response may in part
ccount for the diminished exercise capacity seen in these
atients (21). The results of our study support this
otion. We found that patients with chronotropic incom-
etence had poorer exercise capacity compared with
atients without chronotropic incompetence. In addition,
hange in heart rate correlated with peak oxygen con-
umption. However, in this cohort heart rate explains
nly a quarter of the variation in peak oxygen consump-
ion. Therefore, other parameters, such as age, gender,
ulmonary function, cyanosis, and level of fitness may
lay an important role in determining exercise capacity in
CHD patients. We also found a relationship between
hronotropic incompetence and symptomatic state. Pa-
ients with chronotropic incompetence were more likely
o be in a higher NYHA functional class than patients
ith a normal heart rate response to exercise. Whether
tal heart disease patients stratified by quartiles of heart rate reserve (HRR).his is a causal relationship remains to be determined.
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September 19, 2006:1250–6 Heart Rate Response and Survival in ACHDHeart rate reserve, though a simple and easily obtained
arker, turned out to be a powerful prognostic marker in
CHD independently of antiarrhythmic medication and
xercise capacity. Stratifying patients by diagnostic groups
evealed that a lower heart rate reserve was also associated
ith a greater risk of death in patients with complex
natomy, Fontan circulation, and tetralogy of Fallot. Inter-
stingly, despite their poor exercise capacity, Eisenmenger
atients did not have a correspondingly poor survival, and,
herefore, neither peak oxygen consumption nor heart rate
eserve failed to predict prognosis in this population. We
peculate that in the Eisenmenger patients the limitation to
xercise does not arise from the usual broad constellation of
minous pathophysiologic abnormalities (including poor
entricular function, vascular remodeling, autonomic dys-
unction, etc.) but rather more specifically from exercise-
nduced increase in right-to-left shunting. Thus there is a
cap” on exercise capacity and therefore on heart rate
eserve. This cap may be far below that which would have
een set by the usual pathophysiologic abnormalities which
n turn are responsible for the impaired prognosis. As a
igure 2. Increase in heart rate during exercise (heart rate reserve) (A) and
ecrease in heart rate at the end of exercise (heart rate recovery) (B) in
urviving and nonsurviving patients. Error bars indicate 95% confidence
ntervals.onsequence, their survival is nowhere near as poor as would oe predicted from the exercise capacity. Further work will be
eeded to identify the subset of patients within the Eisen-
enger cohort who are at highest risk of mortality.
In acquired heart disease, both exercise capacity and
hronotropic incompetence are known to be predictors of
oor prognosis (8,9,22,23). Of these, only peak oxygen
onsumption is routinely used for risk stratification, and
ven this is largely limited to acquired chronic heart failure.
n ACHD patients, the prognostic value of both peak
xercise and chronotropic incompetence is far from estab-
ished. The present study shows in a large cohort of ACHD
atients that both parameters of chronotropic incompetence
nd peak oxygen consumption are of prognostic value and
hat heart rate reserve is at least as good a predictor of
ortality in ACHD patients as peak oxygen consumption.
ombining parameters of chronotropic response with peak
xygen consumption enables further risk stratification.
Underlying mechanisms responsible for chronotropic in-
ompetence in ACHD patients are not fully understood. It
ppears likely that chronotropic incompetence is a multifac-
orial phenomenon resulting from the confluence of several
actors which themselves are associated with poor prognosis.
olluci et al. (24) reported that impaired chronotropic
esponse to exercise in patients with chronic heart failure is,
t least in part, due to postsynaptic desensitization of
eta-adrenergic receptors. In addition, it has been demon-
trated that heart rate variability is significantly decreased in
atients with acquired heart disease who are chronotropi-
ally incompetent (25).
It remains to be elucidated whether the prognostic power
f heart rate reserve results from its dependence on mech-
nisms such as exercise capacity, neurohormonal activation,
utonomic dysfunction, and hemodynamic compromise.
his study identifies heart rate reserve as a physiologically
mportant piece of information to extract from a cardiopul-
onary exercise test alongside the usual measurements.
hether specifically targeting abnormal heart rate reserve
ould improve prognosis remains unknown. There are no
ata to suggest that directly intervening on heart rate (e.g.,
nserting a rate-responsive pacemaker) would improve prog-
osis. Rather, for now, we believe these data indicate the
otential utility of this additional information in selecting
atients for special medical or further surgical attention
ecause they are at greater risk of death than the clinician
ight otherwise predict.
tudy limitations. Cardiopulmonary exercise testing in
his study was performed as part of routine evaluation of
atients in the ACHD clinic. All patients were at a tertiary
CHD center and, therefore, it is possible that they may
ot represent the pattern of ACHD that may exist in the
ommunity. Nevertheless, the patients were not restricted to
ny particular narrow diagnostic group but rather covered
he entire spectrum of ACHD diagnoses and included all
egments of the population regardless of age, gender, history,
nd nature of surgery. The number of deaths forming the basis
f this report is limited and further prospective studies with
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Heart Rate Response and Survival in ACHD September 19, 2006:1250–6longer period of observation and a higher number of
linical events are desirable to validate the results reported in
his cohort and to provide information on the potential
esponse to different therapies. This study cannot identify
hy a blunted heart rate response to exercise in ACHD
atients predicts poor prognosis. Indeed, even the mecha-
isms of depressed heart rate responses in ACHD remain
nclear. Now that the prognostic value of heart rate re-
ponses are emerging, further research may be stimulated
hat could elucidate the mechanisms responsible.
onclusions. An abnormal heart rate response to exercise
s prevalent across the spectrum of adult congenital heart
isease and is associated with a greater risk of death. Even
n its own, heart rate reserve is potentially a simple means
f identifying ACHD patients at elevated risk. In combi-
ation with formal measurement of peak oxygen consump-
ion, it identifies a subpopulation with a 3.8-fold elevated
isk of death in the mid term. Exercise testing should be
onsidered as part of the routine assessment of adults with
ongenital heart disease.
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